The UK’s regulatory authority on Friday approved a third COVID-19 vaccine for use in the country, made by the company Moderna.

However, supplies of the new jab are not expected to be available until the spring in a few weeks’ time as the UK has pre-ordered 7 million doses. In trials with more than 30,000, the Moderna vaccine offered nearly 95 per cent protection from severe COVID.